14 April 2021
1300 794 893

Switzer TV

Mad about Money Live

Join Peter Switzer and Paul Rickard for their weekly take on the latest money news.

More videos

Mad about Money Live

Peter Switzer and Paul Rickard discuss the big money stories you need to know about.

Stocks that will rise on vaccination - (ASX: A2M, EVT, AVH, SGR, CSL, APX, ELO)

Peter Switzer speaks to Adam Dawes, Paul Rickard, Danny Lessem and David Dicker.

What happens if you drink a can of soft drink every day?

Dr Ross Walker explains how regularly drinking soft drinks negatively affects your health.

House prices continue to surge but what could kill the boom?!

In this week's episode, Century 21's Charles Tarbey, CoreLogic's Eliza Owen and AMP Capital's Diana Mousina join Peter Switzer.

Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money news in Mad about Money.

Experts love these ASX stocks: TYR, IGO, APX, AVH, WES, OML, XRO

Tribeca's Jun Bei Liu, Switzer's Paul Rickard, Burman Invest's Julia Lee and Aussie Broadband's Phillip Britt join Peter Switzer.

The best options for a coronary artery bypass graft

Dr Ross Walker explains what coronary artery bypass grafting is and what the best types are.

Is it rational to be optimistic on house prices and where should you buy?

Simon Pressley from Propertyology and Ying Yi Ann Cheng from Coolabah Capital talk to Peter Switzer about the outlook for the property market.

Is BHP’s super dividend sustainable?

Paul Rickard speaks to BHP's new CFO David Lamont about the company's half year results.

Mad about Money

Tune in to our latest episode of Mad about Money with Peter Switzer and Paul Rickard.

5 experts and their 5 best stocks for 2021

Joining Peter Switzer this week are Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, Switzer's Paul Rickard, Fairmont Equities' Michael Gable and Coolabah Capital's Ying Yi Ann Cheng.

A vaccine for Alzheimer’s disease

Dr Ross Walker talks us through a study that is currently being undertaken in mice for a potential vaccine for Alzheimer’s disease in the future.

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
1300 794 893
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homeshopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram